Accessibility Menu
Genomma Lab InternacionalB. De C.v. logo

Genomma Lab InternacionalB. De C.v.(OTC) GNMLF

Market Cap$830.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)-57%
5 Year+8%
1 Year-20%
1 Month+1%
$0.83
+0.00%
+0.00Today
Genomma Lab InternacionalB. De C.v. last closing stock price
MetricPriceDate
Last closeUSD 0.832026-07-23
Genomma Lab InternacionalB. De C.v. stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.56%USD 0.832026-07-14
1 month+0.56%USD 0.832026-06-22
3 month-22.08%USD 1.072026-04-09
Year to date-18.87%USD 1.022025-12-29
1 year-20.37%USD 1.042025-07-21
3 year+14.1%USD 0.732023-07-17
5 year+7.63%USD 0.772021-07-23
Since inception-57.44%USD 1.952012-05-04

Genomma Lab InternacionalB. De C.v. Financials at a Glance

Market Cap

$830.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

MX$17.04B

Net Income (TTM)

MX$1.62B

EPS (TTM)

$0.09

P/E Ratio

8.95

Dividend

$0.04

Beta (Volatility)

0.05 (Low)

Price

$0.83

Volume

175

Open

$0.83

Previous Close

$0.83

Daily Range

$0.83 - $0.83

52-Week Range

$0.83 - $1.17

Estimated Earnings Date

Oct 21, 2026

GNMLF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genomma Lab InternacionalB. De C.v.

Genomma Lab Internacional, S.A.B. de C.V. is a leading company in the healthcare sector, specializing in the development, marketing, and distribution of over-the-counter pharmaceutical products and personal care items. Established in 1996 and headquartered in Mexico City, the company operates in various international markets, offering a diverse range of products that cater to consumer health and wellness needs.

Products and Services
  • Wide array of over-the-counter pharmaceutical goods
  • Personal care items including skincare and hair care products
  • Specialized pharmaceuticals for pain management and digestive health
Growth Outlook
  • Revenue of MXN 4.39 billion in Q2 2026, showing strong market demand
  • Net income of MXN 373.97 million in Q2 2026, indicating profitability
  • Consistent product innovation supports long-term growth potential
Financial Highlights
  • Trailing twelve months (TTM) revenue of MXN 16.5 billion, reflecting robust sales performance
  • Net profit margin of 9.52% TTM, showcasing effective cost management
  • Dividend yield of 5.53% TTM, appealing for income-focused investors
Genomma Lab Internacional, S.A.B. de C.V. has established a strong presence in the healthcare market, driven by a comprehensive product portfolio that addresses various consumer needs. The company's recent financial performance highlights its ability to generate significant revenue and maintain profitability, making it an attractive option for potential investors. With a focus on innovation and market expansion, Genomma Lab is well-positioned for future growth in the competitive healthcare landscape.
AI Generated • Jul 27, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

1,658

CEO

Marco Sparvieri

Website

www.genommalab.com

Headquarters

Mexico City, DF 01210, MX

GNMLF Financials

Key Financial Metrics (TTM)

Gross Margin

63.25%

Operating Margin

20.26%

Net Income Margin

9.52%

Return on Equity

14.23%

Return on Capital

20.04%

Return on Assets

6.71%

Earnings Yield

11.17%

Dividend Yield

5.36%

Payout Ratio

60.19%

Stock Overview

Market Cap

$830.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.00B

Volume

175

Avg. Volume

504.365

Financials (TTM)

Gross Profit

MX$10.78B

Operating Income

MX$3.51B

EBITDA

MX$3.79B

Operating Cash Flow

MX$1.25B

Capital Expenditure

-MX$590.54M

Free Cash Flow

MX$802.31M

Cash & ST Invst.

MX$2.41B

Total Debt

MX$7.84B

Genomma Lab InternacionalB. De C.v. Performance Analysis

Genomma Lab InternacionalB. De C.v. annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31MXN 835,844,8129.5%
20232023-12-31MXN 928,208,46111.1%
20242024-12-31MXN 1,015,095,9099.4%
20252025-12-31MXN 913,584,084-10.0%
Genomma Lab InternacionalB. De C.v. sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301689.5%
Q42025-12-31-10.0%
Q12026-03-314.1%
Q22026-06-305.1%
Genomma Lab InternacionalB. De C.v. annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31MXN 0.078.6%
20232023-12-31MXN 0.06-13.1%
20242024-12-31MXN 0.0837.9%
20252025-12-31MXN 0.093.4%
Genomma Lab InternacionalB. De C.v. sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-302231.6%
Q42025-12-31-26.7%
Q12026-03-3154.5%
Q22026-06-30-27.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

MX$4.39B

+1662.1%

Gross Profit

MX$2.83B

+1691.5%

Gross Margin

64.56%

N/A

Market Cap

$830.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$505.17K

N/A

Employees

1,643

N/A

Net Income

MX$373.97M

+1877.2%

EBITDA

MX$801.76M

-4.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

MX$2.41B

-6.9%

Total Debt

MX$7.84B

+57.9%

Accounts Receivable

MX$6.52B

+7.4%

Inventory

MX$1.95B

-8.0%

Long Term Debt

MX$2.41B

-51.5%

Short Term Debt

MX$5.43B

+4418.5%

Return on Assets

6.71%

N/A

Return on Invested Capital

23.32%

N/A

Free Cash Flow

MX$262.99M

-37.8%

Operating Cash Flow

MX$239.86M

-52.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LJUIFSSY Group Limited
$0.40+0.00%
EXETFExtendicare Inc.
$25.28-2.58%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About GNMLF

What is the current price of Genomma Lab InternacionalB. De C.v.?

Genomma Lab InternacionalB. De C.v. is trading at $0.83 per share.

What is the 52-week range for Genomma Lab InternacionalB. De C.v.?

Over the past 52 weeks, Genomma Lab InternacionalB. De C.v. has traded between $0.83 and $1.17.

How much debt does Genomma Lab InternacionalB. De C.v. have?

As of the most recent reporting period, Genomma Lab InternacionalB. De C.v. reported total debt of MX$449.19M.

How much cash does Genomma Lab InternacionalB. De C.v. have on hand?

Genomma Lab InternacionalB. De C.v. reported MX$138.06M in cash and cash equivalents in its most recent financial results.

What is Genomma Lab InternacionalB. De C.v.’s dividend yield?

Genomma Lab InternacionalB. De C.v. currently has a dividend yield of 5.36%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services